{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2006"],"condition":["Metastatic Colorectal Cancer","Exanthema","Colon Cancer","Skin Toxicities","Colorectal Cancer","Colorectal Neoplasms","Skin Rash","Colonic Neoplasms"],"disease":["Metastatic Colorectal Cancer","Exanthema","Colon Cancer","Skin Toxicities","Colorectal Cancer","Colorectal Neoplasms","Skin Rash","Colonic Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2029392"],"study_start_month":["4"],"keyword":["Irinotecan","Anti-EGFr Skin Rash","MCRC","Rectal cancer","Panitumumab","STEEP","STEP","STEPP"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy","description":"A comparison of prophylactic treatment with reactive treatment for skin toxicity observed in patients with metastatic colorectal cancer (mCRC) who are receiving second-line irinotecan-based chemotherapy concomitantly with panitumumab.","dates":{"creation":"2006-04-15"},"accession":"2029392","cross_references":{"ClinicalTrials___gov":["NCT00332163"]}}